ve-panel 2c: research pathway for the use of monoclonal antibodies in hiv prevention.
Published 3 years ago • 227 plays • Length 58:40Download video MP4
Download video MP3
Similar videos
-
1:15:35
challenges and opportunities on the access to future monoclonal antibodies for hiv prevention
-
56:51
ve-panel 2b: future design approaches for hiv vaccine efficacy trials
-
1:02:07
ve-panel 3b: community engagement and involvement in hiv vaccine prevention clinical research
-
12:25
monoclonal antibodies for hiv prevention - carlos del rio
-
22:34
hiv prevention and monoclonal antibodies - myron cohen, md
-
25:27
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 1/3)
-
20:18
vaccines and monoclonal antibodies - shelly karuna, md, mph
-
3:32
monoclonal antibodies and its production
-
4:41
the intravenous administration of monoclonal antibodies
-
3:21
iavi’s global call to access for monoclonal antibodies for covid-19 and other diseases
-
2:33
what do antibodies do? why do we need them?
-
25:21
hivr4p // virtual sa03 hiv & tb: an r&d tale of two vaccines (part 2/3)
-
2:50
clone screening tutorial: selecting hybridomas using hat method
-
1:41
what are monoclonal antibodies?
-
1:37
human biology: monoclonal antibodies
-
12:57
monoclonal antibodies - production and applications
-
1:31
iavi’s project for sustainable access to antibodies
-
26:59
use of technology for hiv treatment and prevention: updates on two cfar grants